Synapse

← EJC Paediatric Oncology

Papers in EJC Paediatric Oncology

Page 4 · newest first

  1. Telomere maintenance mechanisms in neuroblastoma: New insights and translational implicationsEJC Paediatric Oncology · 2024
  2. Prevalence of childhood cancer survivors in Europe: a scoping reviewEJC Paediatric Oncology · 2024
  3. 131-I-MIBG therapy in combination with PARP inhibitors for young adult patient with relapsed neuroblastoma and DNA repair pathway alterationsEJC Paediatric Oncology · 2024
  4. Malignant extracranial germ cell tumors in the Netherlands between 1990 and 2018: Stable incidence and improved survivalEJC Paediatric Oncology · 2024
  5. How we approach early phase clinical trial and off-label therapy consults in pediatric oncology: The New Agents and Innovative Therapy (NAIT) team experienceEJC Paediatric Oncology · 2024
  6. Emergent and underexplored oncolytic viruses for treating pediatric central nervous system tumorsEJC Paediatric Oncology · 2024
  7. CAR T-cells for T-cell acute lymphoblastic leukemiaEJC Paediatric Oncology · 2024
  8. Genome editing approaches for universal chimeric antigen receptor T cellsEJC Paediatric Oncology · 2024
  9. General support of physical exercise programs in pediatric oncology but differences in perception by childhood cancer care professionals at European and North-African/Arab centersEJC Paediatric Oncology · 2024
  10. Overview of current European practice for the management of patients with intracranial germ cell tumoursEJC Paediatric Oncology · 2024
  11. Clinical presentation and outcome of invasive mould disease in paediatric patients with acute lymphoblastic leukaemiaEJC Paediatric Oncology · 2024
  12. Infections in children and adolescents with Acute LeukemiaEJC Paediatric Oncology · 2024
  13. Focus on melanotic neuroectodermal tumor of infancyEJC Paediatric Oncology · 2023
  14. Opportunities for interventional radiology in paediatric oncologyEJC Paediatric Oncology · 2023
  15. Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterationsEJC Paediatric Oncology · 2023
  16. Shared decision making in primary malignant bone tumour surgery in children and young adultsEJC Paediatric Oncology · 2023
  17. Olfactory neuroblastoma in children and adolescents: The EXPeRT recommendations for diagnosis and managementEJC Paediatric Oncology · 2023
  18. A systematic review of health-related quality of life in children and adolescents during treatment for cancerEJC Paediatric Oncology · 2023
  19. Scylla and Charybdis: Unpalatable choices in managing hypodiploid acute lymphoblastic leukemiaEJC Paediatric Oncology · 2023
  20. Virus infections after allogeneic stem cell transplantation in children. ReviewEJC Paediatric Oncology · 2023
  21. Salivary gland carcinomas in children and adolescents: A retrospective analysis of the European Cooperative Study Group for Pediatric Rare Tumours (EXPeRT)EJC Paediatric Oncology · 2023
  22. Solutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC)EJC Paediatric Oncology · 2023
  23. Systematic review: Care provided by grandparents of children with a chronic disease or a disabilitySHILAP Revista de lepidopterología · 2023
  24. Palliative care services in paediatric oncology centres across Europe: A cross-sectional surveyEJC Paediatric Oncology · 2023
  25. Tunneled vascular access surgery in pediatric oncology; Experience from a national pediatric oncology centerEJC Paediatric Oncology · 2023
  26. Nausea and nausea-related symptoms in children with cancer: Presence, severity, risk factors and impact on quality of life during the first year of treatmentEJC Paediatric Oncology · 2023
  27. The neonatal blood spot metabolome in retinoblastomaEJC Paediatric Oncology · 2023
  28. Sleep problems and impact of obstructive hydrocephalus in newly diagnosed pediatric brain tumor patientsEJC Paediatric Oncology · 2023
  29. Nuclear medicine techniques in paediatric body oncology: Present and futureEJC Paediatric Oncology · 2023
  30. Respiratory viral infections in pediatric hematology/oncology patientsEJC Paediatric Oncology · 2023
  31. Osteonecrosis in children and young adults treated for acute lymphoblastic leukemia: A scoping reviewEJC Paediatric Oncology · 2023
  32. Bacterial bone and joint infections in children with leukaemia or following haematopoietic cell transplant: A systematic review of published casesEJC Paediatric Oncology · 2023
  33. Diagnostics and therapy of paediatric patients with febrile neutropeniaEJC Paediatric Oncology · 2023
  34. Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single centerEJC Paediatric Oncology · 2023
  35. Comparing routinely collected population level healthcare data to a prospective clinical study of Wilms Tumour in EnglandEJC Paediatric Oncology · 2023
  36. Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinibEJC Paediatric Oncology · 2023
  37. High prevalence of long-term and late effects in a South African childhood cancer survivor cohortEJC Paediatric Oncology · 2023
  38. Erythrocyte-incorporated 6-mercaptopurine metabolite levels are not affected by recent drug administration during maintenance therapy for childhood acute lymphoblastic leukemiaEJC Paediatric Oncology · 2023
  39. European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcomaEJC Paediatric Oncology · 2023
  40. Age-related biological differences in children’s and adolescents’ very rare tumorsEJC Paediatric Oncology · 2023
  41. Leiomyosarcoma and liposarcoma in young patients: The national netsarc+ network experienceEJC Paediatric Oncology · 2023
  42. The impact of infertility and physical late effects on psycho-social well-being of long-term childhood cancer survivors: A cross-sectional studyEJC Paediatric Oncology · 2023
  43. The role of cancer predisposition syndrome in children and adolescents with very rare tumoursSHILAP Revista de lepidopterología · 2023
  44. Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspectiveEJC Paediatric Oncology · 2023
  45. Persistence of racial and ethnic disparities in risk and survival for patients with neuroblastoma over two decadesEJC Paediatric Oncology · 2023
  46. Efficacy of convection enhanced delivery of MTX110 (soluble panobinostat) in preclinical Diffuse Intrinsic Pontine Glioma models using metabolic hyperpolarized 13C imagingEJC Paediatric Oncology · 2023
  47. Fluorescence guided surgery using indocyanine green for pulmonary osteosarcoma metastasectomy in pediatric patients: A feasibility studyEJC Paediatric Oncology · 2023
  48. Incidence and surveillance of acute cardiovascular toxicities in paediatric acute lymphoblastic leukaemia: A retrospective population-based single-centre cohort studyEJC Paediatric Oncology · 2023
  49. Outcomes in lung-only metastatic rhabdomyosarcoma: An analysis of data from the European paediatric Soft tissue sarcoma Study Group MTS 2008 studyEJC Paediatric Oncology · 2023
  50. Risk factors in pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST): Results from the French Pediatric Oncology Society (SFCE) cohortEJC Paediatric Oncology · 2023